Protein restriction in the pregnant mouse modifies fetal growth and pulmonary development: role of fetal exposure to {beta}-hydroxybutyrate.
Maternal undernutrition during sensitive periods of pregnancy results in offspring predisposed towards the development of a number of diseases of adulthood, including hypertension and diabetes. In order to determine the nature of any gross alterations in fetal growth during early organogenesis, we supplied timed-mated pregnant mice with diets containing 6% protein (6%P), 9% protein (9%P) or 18% protein (18%P; control) from day 0 of pregnancy. At embryonic days 11 (E11), 12 (E12) and 13 (E13), females were killed and fetuses removed. Gross morphological analysis revealed that fetal limb growth was impaired between E11 and E12 in 6%P animals, but this recovered by E13. Likewise, fetal liver growth and lung branching morphogenesis were seen to exhibit an initial growth impairment at E12 followed by a rapid recovery by E13. Coincident with the observed changes in fetal growth, we noted an elevation in maternal hepatic triglyceride content, expression of the ketogenic 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2) and circulating plasma β-hydroxybutyrate (BOHB). In addition, fetal liver Hmgcs2 expression was switched on by E13 in both 6%P- and 9%P-exposed animals. Exogenous BOHB did not influence branching morphogenesis in fetal lung explant cultures; however, we cannot rule out the possibility that this may occur in vivo. In conclusion, we find that disturbance of fetal growth by maternal dietary protein restriction is associated and therefore potentially indicated by changes in maternal and fetal ketone body metabolism.
Langley-Evans
Simon C
SC
University of Nottingham, Nutritional Sciences, Sutton Bonington Campus, Division of Nutritional Sciences, Loughborough, Leicestershire, UK. simon.welham@nottingham.ac.uk.
Daniel
Zoe C
ZC
Wells
Cathy A
CA
Ryan
Kevin J P
KJ
Plant
Richard
R
Welham
Simon J M
SJ
D020155:3-Hydroxybutyric Acid / Q000633:toxicity*; D000818:Animals; D004044:Dietary Proteins / Q000378:metabolism; D005260:Female; D005317:Fetal Growth Retardation / Q000209:etiology / Q000503:physiopathology*; D006904:Hydroxymethylglutaryl-CoA Synthase / Q000502:physiology*; D008168:Lung / Q000187:drug effects / Q000196:embryology* / Q000254:growth & development*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology*; D011297:Prenatal Exposure Delayed Effects / Q000503:physiopathology*; D011488:Protein Deficiency / Q000503:physiopathology*
D004044:Dietary Proteins; C000607500:HMGCS2 protein, mouse; D006904:Hydroxymethylglutaryl-CoA Synthase; D020155:3-Hydroxybutyric Acid